Cytotoxic Drugs
Showing 1 - 25 of >10,000
Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,
Withdrawn
- Constitutional Mismatch Repair Deficiency Syndrome
- +11 more
- Biospecimen Collection
- +2 more
-
Palo Alto, California
- +8 more
Sep 9, 2022
Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)
Recruiting
- Malignant Pleural Mesothelioma
- Chemotherapy Effect
- hyperthermic intrathoracic chemotherapy
-
Cairo, EgyptAin Shams University hospitals
Aug 18, 2022
Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching
Not yet recruiting
- Gastrointestinal Cancer
- +2 more
- Avatrombopag
- Matching Placebo
-
Miami, Florida
- +1 more
Mar 6, 2023
Fungal Infections in Intensive Care Units of Assiut University
Not yet recruiting
- Fungal Infection
- (no location specified)
May 25, 2023
PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)
Not yet recruiting
- PD-1 Antibody
- +3 more
- L-DEP and PD-1 antibody
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Mar 8, 2023
Follow up After TACE by Elastography and Color Doppler.
Not yet recruiting
- Hepatocellular Carcinoma
- US
- (no location specified)
Oct 2, 2023
Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)
Not yet recruiting
- Non-Muscle Invasive Bladder Cancer
- HER2
- (no location specified)
Jul 16, 2023
Sarcoma, Kaposi, HIV Trial in United States (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Bleomycin sulfate
- +4 more
-
Los Angeles, California
- +4 more
Oct 26, 2021
Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,
Not yet recruiting
- Oral Cancer
- Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
- +2 more
-
Cairo, Egypt11 Saraya El Manial
Jul 8, 2022
Advanced or Metastatic Solid Tumors Trial in Toulouse, Villejuif, Barcelona (W0101 - Cohort A1, W0101 - Cohort A2, W0101 -
Active, not recruiting
- Advanced or Metastatic Solid Tumors
- W0101 - Cohort A1
- +2 more
-
Toulouse, France
- +2 more
Dec 19, 2022
HER2, Colorectal Cancer Trial (Disitamab Vedotin Combined With Fruquintinib)
Not yet recruiting
- HER2
- Colorectal Cancer
- Disitamab Vedotin Combined With Fruquintinib
- (no location specified)
Dec 21, 2022
Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)
Terminated
- Serologically Active Adult Systemic Lupus Erythematosus
- Autologous EBV specific CTL infusion
-
Nantes, France
- +2 more
Mar 24, 2022
NSCLC Trial (Chemotherapy, Alflutinib plus chemo)
Not yet recruiting
- NSCLC
- Chemotherapy
- Alflutinib plus chemotherapy
- (no location specified)
Jan 25, 2022
Biliary Tract Tumors Trial in Seoul (Durvalumab, Tremelimumab, Gemcitabine)
Active, not recruiting
- Biliary Tract Neoplasms
- Durvalumab
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 26, 2021
Nursing Care for Gastrointestinal Cancer Patients Trial in Erzurum (routine care group, Care in accordance with Orem's theory
Active, not recruiting
- Nursing Care for Gastrointestinal Cancer Patients
- routine care group
- Care in accordance with Orem's theory group
-
Erzurum, Yakutiye, TurkeyAtaturk University
Jan 30, 2023
Breast Cancer Trial in Fayoum (Tocilizumab, traditional Covid -19 therapy)
Completed
- Breast Cancer
- Tocilizumab
- traditional Covid -19 therapy
-
Fayoum, EgyptALsafwa specialized hospital
Oct 31, 2022
Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer Trial in Uppsala (Salovum and SPC-flakes active or )
Recruiting
- Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer
- Salovum and SPC-flakes active or placebo
-
Uppsala, SwedenUniversity hospital
May 18, 2022
Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Durvalumab
- Rintatolimod
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 23, 2023
Gynecologic Cancer, Chemo-Induced Change Trial in Hong Kong (Scalp cooling Paxman Orbis II system, Standard treatment)
Active, not recruiting
- Gynecologic Cancer
- Chemotherapy-Induced Change
- Scalp cooling Paxman Orbis II system
- Standard treatment
-
Hong Kong, Hong KongThe University of Hong Kong
Feb 23, 2022
MSI, dMMR Colorectal Cancer Trial in Paris (Monalizumab/MEDI5257)
Not yet recruiting
- MSI
- dMMR Colorectal Cancer
-
Paris, FranceDepartment of medical oncology - Saint-Antoine Hospital
Nov 28, 2023
Prostate Cancer, Radical Prostatectomy Trial in Boston (Microdevice)
Enrolling by invitation
- Prostate Cancer
- Radical Prostatectomy
- Microdevice
-
Boston, MassachusettsBrigham and Women's Hospital
Aug 16, 2022
Prostatic Tumors, Castration-Resistant Trial in Darlinghurst, Pretoria (225^Ac-PSMA-617, 68^Ga-PSMA-11)
Recruiting
- Prostatic Neoplasms, Castration-Resistant
- 225^Ac-PSMA-617
- 68^Ga-PSMA-11
-
Darlinghurst, Australia
- +1 more
Nov 23, 2022
Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)
Recruiting
- Recurrent IDH1/2 Mutated Glioma
-
Paris, FrancePitie Salpetriere Hospital
Aug 29, 2022
Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - NSCLC Trial in Kansas City, Overland Park, Lee's Summit (Cabozantinib,
Not yet recruiting
- Lung Cancer
- +3 more
-
Kansas City, Kansas
- +3 more
May 12, 2023
Sarcoma Trial in Guangzhou (chidamide and toripalimab)
Recruiting
- Sarcoma
- chidamide and toripalimab
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 4, 2022